Postprandial glucose for all patients
| . | Arithmetic mean . | . | . | . | . | . | Point estimate (95% confidence limits)* . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | All . | . | Children . | . | Adolescents . | . | All . | Adolescents/children . | . | |||||||
| . | Glu . | RHI . | Glu . | RHI . | Glu . | RHI . | Glu/RHI . | Glu . | RHI . | |||||||
| n | 20 | 20 | 10 | 10 | 10 | 10 | 20 | 10 | 10 | |||||||
| BG AUC(0–1h) (mg · h−1 · dl−1) | 57 | 79 | 50 | 75 | 65 | 82 | 73% (59, 90) | 131% (69, 287) | 108% (70, 171) | |||||||
| BG AUC(0–2h) (mg · h−1 · dl−1) | 179 | 263 | 149 | 258 | 208 | 267 | 68% (56, 82) | 140% (82, 269) | 103% (74, 144) | |||||||
| BG AUC(0–4h) (mg · h−1 · dl−1) | 419 | 627 | 320 | 590 | 518 | 664 | 67% (55, 80) | 162% (87, 395) | 113% (81, 159) | |||||||
| BG AUC(0–6h) (mg · h−1 · dl−1) | 641 | 801 | 492 | 729 | 790 | 872 | 80% (67, 95) | 161% (88, 369) | 120% (82, 179) | |||||||
| BGmax (mg/dl) | 298 | 352 | 273 | 349 | 324 | 355 | 85% (77, 93) | 119% (92, 155) | 102% (84, 124) | |||||||
| ΔBGmax (mg/dl) | 166 | 224 | 142 | 216 | 189 | 232 | 74% (64, 86) | 133% (84, 226) | 107% (81, 143) | |||||||
| BGmin (mg/dl) | 211 | 193 | 180 | 179 | 242 | 207 | 109% (93, 128) | 135% (95, 199) | 115% (83, 162) | |||||||
| . | Arithmetic mean . | . | . | . | . | . | Point estimate (95% confidence limits)* . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | All . | . | Children . | . | Adolescents . | . | All . | Adolescents/children . | . | |||||||
| . | Glu . | RHI . | Glu . | RHI . | Glu . | RHI . | Glu/RHI . | Glu . | RHI . | |||||||
| n | 20 | 20 | 10 | 10 | 10 | 10 | 20 | 10 | 10 | |||||||
| BG AUC(0–1h) (mg · h−1 · dl−1) | 57 | 79 | 50 | 75 | 65 | 82 | 73% (59, 90) | 131% (69, 287) | 108% (70, 171) | |||||||
| BG AUC(0–2h) (mg · h−1 · dl−1) | 179 | 263 | 149 | 258 | 208 | 267 | 68% (56, 82) | 140% (82, 269) | 103% (74, 144) | |||||||
| BG AUC(0–4h) (mg · h−1 · dl−1) | 419 | 627 | 320 | 590 | 518 | 664 | 67% (55, 80) | 162% (87, 395) | 113% (81, 159) | |||||||
| BG AUC(0–6h) (mg · h−1 · dl−1) | 641 | 801 | 492 | 729 | 790 | 872 | 80% (67, 95) | 161% (88, 369) | 120% (82, 179) | |||||||
| BGmax (mg/dl) | 298 | 352 | 273 | 349 | 324 | 355 | 85% (77, 93) | 119% (92, 155) | 102% (84, 124) | |||||||
| ΔBGmax (mg/dl) | 166 | 224 | 142 | 216 | 189 | 232 | 74% (64, 86) | 133% (84, 226) | 107% (81, 143) | |||||||
| BGmin (mg/dl) | 211 | 193 | 180 | 179 | 242 | 207 | 109% (93, 128) | 135% (95, 199) | 115% (83, 162) | |||||||
Data are baseline corrected.
Point estimates (95% confidence limits) for the ratio of treatment means according to Fieller’s Theorem. Glu, glulisine.